Ecovyst Reports Second Quarter 2026 Results and Raises 2026 Outlook
Ecovyst Inc. (NYSE: ECVT) reported Q2 2026 sales of $250.0 million, up 42% year over year, and net income of $10.7 million. Adjusted EBITDA rose 27% to $53.1 million. The company completed the Calabrian sulfur dioxide acquisition on June 30, 2026 and raised full-year 2026 Adjusted EBITDA guidance to $195 million to $207 million.
How this was made
The 30-second read
Why it matters
Q2 results show strong sales growth and higher Adjusted EBITDA, and management raised 2026 guidance to reflect Calabrian contributions in the second half. The outlook remains mixed for virgin sulfuric acid, with expected lower spot sales opportunities in Q3 and Q4.
Market read
Traders can update models for 2026 EBITDA, free cash flow, and capex based on the raised ranges and the quantified Calabrian impact in 2H.
What to watch
Net debt leverage increased due to the Calabrian term loan, and higher manufacturing, transportation, and inflation costs partially offset EBITDA gains, which could cap upside if margins compress.
Background
Ecovyst completed the sale of its Advanced Materials & Catalysts business on Dec. 31, 2025, so current results are from continuing operations; it also acquired the Calabrian sulfur dioxide and derivatives business on June 30, 2026.
Ticker impact
Ecovyst reported Q2 2026 results and raised full-year 2026 Adjusted EBITDA guidance to $195 million to $207 million.
Likely positive near-term bias as traders reprice 2H EBITDA and free cash flow; watch for any skepticism around integration and virgin acid softness.
The article discloses specific Q2 performance (sales, Adjusted EBITDA, operating cash flow) and a quantified full-year guidance increase tied to Calabrian contributions, which is actionable for valuation and positioning.
Market effects
Strength in regenerated and virgin sulfuric acid demand signals supportive conditions for sulfur-based industrial inputs and related derivatives demand.
No specific regional demand or plant disruption details beyond Waggaman and Calabrian integration.
Limited direct global macro linkage; primarily company-specific operating and acquisition-driven outlook.
Counterpoint
Raised EBITDA guidance may be partially acquisition-driven, while the company still expects lower virgin sulfuric acid spot sales in Q3 and Q4, leaving downside risk if demand softens.
Key entities
- public_companyEcovyst Inc.
NYSE-listed sulfuric acid and sulfur dioxide derivatives producer reporting Q2 2026 results and revised 2026 guidance.
- acquisition_targetCalabrian sulfur dioxide and related derivatives business
INEOS Enterprises business acquired June 30, 2026, expected to contribute to 2H 2026 results and synergies.
- assetWaggaman sulfuric acid plant
Location acquired in May 2025, cited as contributing to virgin sulfuric acid volume growth.
